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Abstract: Precision medicine has 
captured the imagination of the 
medical community with visions of 
therapies precisely targeted to the 
specific individual’s genetic, biological, 
social, and environmental profile. 
However, in practice it has become 
synonymous with genomic medicine. 
As such its successes have been limited, 
with poor predictive or clinical value 
for the majority of people. It adds little 
to lifestyle medicine, other than in 
establishing why a healthy lifestyle is 
effective in combatting chronic disease. 
The challenge of lifestyle medicine 
remains getting people to actually 
adopt, sustain, and naturalize a 
healthy lifestyle, and this will require 
an approach that treats the patient as 
a person with individual needs and 
providing them with suitable types of 
support. The future of lifestyle medicine 
is holistic and person-centered rather 
than technological.
Keywords: precision medicine; 
genomics; epigenetics; microbiome; 
caloric restriction; genetic risk 
score; individual support; social 
connectedness
While “precision medicine” has been described as an approach that integrates individual 
differences in lifestyle, environment, and 
biology, in actual practice it is simply a 
rebranding of genomic medicine. 
Genomics dominates in almost all 
research papers pertaining to precision 
medicine with the underlying assumption 
that, at its root, disease primarily results 
from genetics. As we shall see, the use of 
the term “precision” is aspirational and 
prematurely hopeful rather than 
descriptive. Even when the alternative 
term “personalized medicine” is used it 
primarily refers to determining what 
subgroup an individual belongs to rather 
than to medicine that considers the 
personhood and individuality of the 
patient.1
Lifestyle medicine, while recognizing 
that genes may predispose to various 
diseases, nonetheless postulates, based 
on overwhelming evidence, that most 
chronic disease results from lifestyle 
factors. So, the question is, “Should the 
future of lifestyle be centered on genetics 
or on lifestyle as the core factor for 
everyone in remaining disease-free and 
independent as long as possible? Should 
it be technological or holistic and 
humanistic?”
Lifestyle medicine has 3 simple goals 
for the individual: to remain healthy as 
long as possible, to remain independent 
as long as possible, and to live as long as 
possible. In other words, the 3 things we 
are working against are disease, 
dependency, and death. Notably, we are 
always working against time since the 
longer an unhealthy lifestyle is left 
unchecked, the shorter the time until one 
or more of these 3 possibilities will be 
realized. Ideally, we do not want to 
simply increase life span; we want to 
increase health span2 and compress 
morbidity.3-5
Genomic medicine is still in its infancy 
and currently the preponderance of 
evidence favors the lifestyle approach. 
Thousands of studies demonstrate not 
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only that poor lifestyle increases the risk 
of chronic disease but that healthy 
lifestyle changes can reduce the risk of 
chronic disease, in some cases slowing 
or even reversing its progression.
There are 3 areas in which precision 
medicine could potentially be of value to 
lifestyle medicine:
•• Establishing a causal basis for the 
known effectiveness of lifestyle 
recommendations
•• Earlier identification of risk, with a 
motivating effect for adopting lifestyle 
changes at an earlier age
•• Individualizing lifestyle 
recommendations to deal with 
differences in response
How Genomic Medicine 
Helps Explain the 
Effectiveness of 
Lifestyle Medicine
In recent decades, advances in 
genomics have helped explain precisely 
why lifestyle changes work.
The first discovery was epigenetic 
change and gene methylation in the 
mid-1970s.6 While it had been earlier 
recognized that every human cell 
contains the same genetic material, the 
question was how cells were able to 
differentiate during embryogenesis and 
how genes were able to be either 
expressed or silenced. This resulted in 
the discovery of heritable epigenetic 
changes and finally epigenetic changes 
as a result of diet and exercise. In turn 
this provided insight into how 
inflammation and oxidative stress could 
affect gene expression and provided a 
pathway to underpinning lifestyle 
medicine with fundamental science. 
Interest in this area has grown 
substantially since 2006. We now know 
that what is important is the complex 
interplay within the whole genome, with 
genes being turned on and off in 
response to cellular exposures to 
chemical gradients and physiological 
stressors.7
The second discovery was that of the 
human gut biome.8 Although the 
significance of the microbiome was first 
suspected in the mid-1980s,9 the advent 
of new genomic technologies in the 21st 
century made it possible to identify 
thousands of distinct species and families 
of bacteria populating the human gut. 
For the first time it was possible to see 
the effects of diet, exercise, and 
probiotics on the ecology of the gut and 
to see the effect of microbiomic diversity 
and composition on risk of chronic 
disease, including certain infectious 
diseases. Interest in this area has been 
rapidly increasing since 2013.
The third discovery was the effect of 
various forms of caloric restriction 
(CR),10,11 including fasting-mimicking 
diets12 and time-restricted feeding,13 on 
gene expression,14 on the composition 
and function of gut microbiota,15 and 
via differential stress response on 
cancerous cells.16,17 CR has been found 
to have benefits for autophagy induction 
(necessary to destroy dysfunctional 
cellular components),18-20 which has 
potential impacts on increasing healthy 
longevity.21,22 Interestingly, aspirin has 
been found to display similar features to 
CR.23 It has been hypothesized that 
moderate intermittent stressors, like CR, 
may mobilize body systems to work 
more effectively.24 Whereas the benefits 
of fasting had been proclaimed for more 
than 2000 years, the underlying 
mechanisms have only been placed on 
a firm scientific footing within the last 
10 years.
Paradoxically, these discoveries 
diminish the importance of pure genetics 
as an explanatory factor in disease. 
Epigenetic change and microbiome 
composition and function are driven by 
diet and physical activity, which along 
with CR, are largely a matter of choice 
rather than genetic determinism. Studies 
of monozygotic twins who are 
genetically identical but disease-
discordant have found epigenetic25,26 and 
microbiomic differences,27-29 which 
strongly suggest that lifestyle and 
environment may largely override 
genetics, at least for some diseases. Two 
further discoveries complicate the 
genetic picture: microchimerism and 
somatic mosaicism. In microchimerism, a 
woman’s body may contain fetal cells 
and alien genetic material from her child, 
which persist for decades in different 
tissues with the potential for both 
beneficial and adverse effects.30,31 
Somatic mosaicism is the occurrence of 
genetically distinct populations of cells 
within an individual due primarily to 
mutations during embryogenesis and to 
mutations during cell division over the 
course of a lifetime,32-34 which may 
accumulate with ageing.35
In the face of epigenetics, 
microbiomics, microchimerism, and 
somatic mosaicism, the search for risky 
genes for chronic disease, rather than 
being a cost-saving fast track to 
accelerated medical progress, may 
instead turn out to be an expensive blind 
alley. As one review of the progress of 
genomic medicine put it, “Soccer is the 
sport of the future in America . . . and it 
always will be.”36 Claims made for 
precision medicine, which always appear 
to be just over the horizon, may well fall 
into the same category.37
While genomic medicine has had some 
successes in relation to targeting drugs 
and gene therapies for some rare genetic 
variants38 and therapies for some 
cancers,39 in general the results have 
been mixed.40 Even diseases such as 
cancers may be 70% to 90% non-
genomic in genesis,41,42 which suggests it 
would be better to promote prevention 
than cure.
Animal experimentation has revealed 
effects of diet and activity, and specific 
dietary components that also 
demonstrably apply to humans. An 
extreme case is that of intermittent CR, 
which demonstrably increases longevity 
in species as diverse as yeast, nematodes, 
mice, and humans.43 If human genetic 
diversity were a key factor in chronic 
disease, animal models would be almost 
worthless. Changes in disease patterns 
when East Asian or indigenous peoples44 
adopt a Western lifestyle, as well as the 
increases in chronic diseases since the 
second half of the 20th century,45 
strongly suggest that chronic disease is 
primarily non-genetic in origin.
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The Success of Lifestyle 
Medicine in the Absence 
of Genetic Information
The theoretical basis of lifestyle 
medicine has changed significantly over 
the past decade. Cholesterol has reduced 
importance as a risk factor for 
cardiovascular disease (CVD),46-49 with 
more emphasis on chronic 
inflammation50,51 (or metaflammation52) 
and oxidative stress53 and the interaction 
between the two54 (which have been 
referred to as oxy-flammation55 or as an 
oxidative-inflammatory cascade56) as key 
factors in the genesis of chronic diseases 
in general and in their complications.57,58 
In the context of aging-related disease, 
this has been referred to as 
“inflammaging.”59-62
What integrates many aspects of a 
healthy lifestyle is mitochondrial 
dynamics and its relationship with 
inflammation, oxidative stress, and 
chronic disease.63-65 Poor lifestyle may 
cause mitochondrial dysregulation and 
dysfunction,66 while exercise67-69 and 
caloric restriction70 may improve 
mitochondrial function. Mitochondrial 
function has also been identified as a 
potential target for mitigating the effects 
of age-related chronic disease.71,72 It has 
been hypothesized that cancers, rather 
than being caused by somatic mutation, 
may be caused by or promoted by 
mitochondrial dysfunction (based in part 
on the role of mitochondrial cell 
signaling on apoptosis).73-78 If true, this 
would help explain how a healthy 
lifestyle reduces cancer risk.
Epigenetic mechanisms show that 
genes are not destiny. Instead, there is an 
interplay between genetic and lifestyle 
factors, both prenatal and over the life 
course, influencing gene expression and 
the potential for a given disease to 
become a reality.79 The ecology of the 
human gut and the makeup of the 
species with which it is populated also 
demonstrably play a role in human 
health.80 Lifestyle factors mediate the 
composition of and changes in gut flora, 
which in turn affect the risk of chronic 
disease. The microbiome also appears to 
be independent of host genetics81 but is 
affected by both diet82,83 and activity,84 
independently of one another.85
Last, there is now greater emphasis on 
activity generally rather than just 
exercise as a key factor in maintaining a 
lifetime of health, with a role in reducing 
oxidative stress.86,87 Physical inactivity 
has been linked to multiple chronic 
diseases including coronary artery 
disease, type 2 diabetes (T2D), various 
cancers, mental illness, and 
dementia.88-95 Conversely, increasing 
physical activity may assist in secondary 
prevention or reversal of such diseases96 
and reduce mortality in survivors of 
breast, bowel, and prostate cancers97 as 
well as increase brain volumes and 
improve memory in older adults,98 
reduce depressive symptoms and the 
risk of relapse in depression 
sufferers.99-101 The latter is particularly 
important given the massive increase in 
anti-depressant use in the West and the 
association between anti-depressant use 
and increased risk of CVD.102 Yet 
between 2001 and 2015, physical 
inactivity rose from 27% to 37% in 
developed countries, placing a further 
10% of the population at risk.103
In summary, we now have a more 
complex theoretical base for looking at 
chronic disease and a clearer perspective 
on the relative importance of different 
lifestyle factors, much of it derived from 
population and clinical studies or cell 
and molecular biology, rather than 
genetics. One complication in many 
studies is that lifestyle behaviors tend to 
cluster. People with a healthy diet also 
tend to be less likely to smoke and more 
likely to be physically active; those with 
a less healthy diet and in particular those 
who eat the most meat tend to have an 
less healthy lifestyle overall.104 A study 
that only looks at one lifestyle factor 
risks confounding from other 
unmeasured lifestyle factors. This in itself 
highlights the need for a holistic 
approach.
The power of the lifestyle approach is 
that despite the changes in how we 
explain chronic disease and its 
prevention, the theoretical changes have 
simply served to reinforce the same 
recommendations while providing ever 
deeper explanations for their 
effectiveness.
Major studies over the past few years 
have reinforced existing 
recommendations105-107 but also provided 
some surprises. A major Canadian 
study,108 centered on 4 lifestyle factors 
(smoking, alcohol consumption, physical 
activity, and diet), found that those who 
had a healthy lifestyle in relation to all 4 
factors could have a life expectancy up 
to 18 years longer than those who scored 
poorly on all 4 factors. Most surprisingly, 
the reduction in life expectancy as a 
result of physical inactivity was just as 
high as the reduction from smoking, and 
both were twice as high as the effect of 
diet with minimal reduction in life 
expectancy from excessive alcohol 
consumption. A study of the risk factors 
for being metabolically obese normal-
weight,109 using factor analysis, found 
not 1 but 2 different dietary approaches 
that reduced this risk: a “healthy” 
approach (high in fruit, vegetables, and 
low-fat dairy) and a “prudent” approach 
(high in fish and whole grains, low in 
refined grains, sweets, sugars, boiled 
potatoes, and cured meats), as well as 2 
diets that increased the risk, designated 
as “fat, meat, and alcohol” and “coca 
cola, hard cheese, and French fries.” 
Thus, within the lifestyle paradigm there 
is still room for diversity both in how 
people stay healthy as well as how they 
become chronically ill. Two recent 
studies have found that a healthy lifestyle 
significantly reduces the risk of CVD and 
diabetes for both those who are 
genetically at risk and the general 
population.110,111
Michael Pollan’s advice, “Eat Food. Not 
too much. Mostly Plants,”112 is supported 
by a growing body of research. 
Predominantly plant-based dietary 
patterns, both vegetarian and 
Mediterranean, are associated with 
increased longevity and significant 
reductions in risk of chronic 
disease.113-116 Several small studies have 
even found evidence that broad-based 
intensive interventions, which include 
such dietary patterns, may slow and even 
reverse various chronic diseases, 
including coronary artery disease117-120 
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and age-related cognitive 
impairment.121,122 Community-based 
programs that encourage such eating 
patterns demonstrably result in 
significant reductions in risk factors for 
coronary artery disease among program 
participants, often within a very short 
period of time.123,124 Eating less red meat 
significantly reduces risk of type 2 
diabetes,125 while predominantly 
plant-based eating126,127 may markedly 
improve glycemic control, reduce 
medication use, and potentially reverse 
complications.128-131
Would Knowing Genetic 
Risk Make a Difference?
In unpacking this question, there are 3 
issues to consider: “knowing,” “risk,” and 
“make a difference.”
On the question of “knowing,” 
genomics produces ambiguous evidence 
at best for chronic disease (as opposed 
to rare genetic syndromes) and at worst 
spurious associations. One example is 
the association of over a thousand genes 
with educational attainment.132 Social 
disadvantage may be associated with 
race, so racial differences in gene 
frequency could spuriously suggest a 
causative association between genes and 
education level, health, or economic 
achievement. One example of such a 
racial difference is the APOE4 gene, 
which is found in 25% to 40% of 
indigenous people across the world, 
while only found in around 12% of 
non-indigenous people.133
A core concept in genomics is gene 
penetrance, the likelihood that carrying 
one or more copies of genes associated 
with a disease will actually result in that 
disease.134 However, genomic research 
involves populations in which the 
majority of people lead an unhealthy 
lifestyle. Thus, estimates of gene 
penetrance are contaminated by the 
effects of the gene-lifestyle interaction.135 
With as much as 80% of chronic disease 
attributable to lifestyle,136 this interaction 
is likely to be significant. A large part of 
gene penetrance may be explicable 
purely in terms of lifestyle and actual 
absolute risk from such genetic risks may 
be grossly overestimated. Genetic risk 
may largely be vulnerability to the effects 
of an unhealthy lifestyle. Estimates of 
gene penetrance also require some 
matching between genes and diagnosed 
disease; however, the rate of medical 
misdiagnosis may be as high as 10% to 
15%,137 significantly adding to the 
uncertainty of any association found.
Some recent studies suggest that 
genetic risk is readily modifiable by 
lifestyle change. A large study found that 
women who were in the highest decile 
for nonmodifiable risk of breast cancer 
but who had low BMI, did not drink or 
smoke, and did not use menopausal 
hormone therapy had risks comparable 
to an average woman in the general 
population.138 Similarly, individuals in the 
top quintile of genetic risk for incident 
coronary events who had at least 3 of 4 
healthy lifestyle factors (no smoking, 
BMI <30, physical activity at least once 
weekly, and a healthy diet) had a 46% 
lower relative risk of coronary events 
compared with those with a less 
favorable lifestyle.139 In both cases, even 
a moderately healthy lifestyle 
significantly reduced genetic risk. A 
study of genetic risk versus lifestyle 
factors in relation to colorectal cancer 
found that lifestyle factors had more 
weight than the genetic score.140 Other 
studies have further shown that lifestyle 
factors account for most of the risk in 
relation to CVD.141
A systematic review of the FTO 
genotype (a variant related to increased 
risk of obesity) and weight loss found 
that carriers responded equally well to 
weight-loss interventions as 
noncarriers.142 Another study, the 
DIETFITS study,143 looked at a low-
carbohydrate and a low-fat diet to 
identify any difference in outcomes 
within groups as a result of genetic 
differences or in insulin dynamics. But 
the study found that at 12 months there 
was no significant difference in outcome 
and neither of the potential predisposing 
factors could identify which diet was 
better for whom.
This sampling of studies demonstrates 
that whatever the future may hold in 
relation to teasing out gene-disease links, 
a healthy lifestyle must still play the 
major role in mitigating risk. An 
unwarranted emphasis on genetic factors 
may simply dilute the message that 
taking responsibility for positive lifestyle 
behaviors may prevent, delay, or 
attenuate most premature disease. It may 
focus too much on individual genetic 
risk at the expense of the lifestyle risks 
that everyone faces.
The second aspect of genetic risk is to 
what extent it is a meaningful concept. It 
has been estimated that an individual 
may carry hundreds of genes associated 
with increased risk of various 
diseases144,145 for which they will never 
display any sign. So, what does it mean 
to say that the genes carry a risk? If each 
person has a unique genetic profile of 
several hundred variants associated with 
disease, how could this inform any 
clinical decision? Given that most people 
are healthy most of the time as are those 
around them, to what extent would this 
simply undermine genetic risk as a factor 
to be considered?146
A person may carry a gene associated 
with increased risk for a disease without 
any familial history of the disease. They 
(and/or their family) may also possess 
one or more genes that modify or nullify 
the effect of the first gene such that their 
risk of that disease is effectively nil.147 
Not only genetics but familial patterns of 
disease may be important,148 and even 
then, the impact of shared lifestyle and 
environmental exposures cannot be 
dismissed. Complicating matters further, 
a SNP (single nucleotide polymorphism) 
protecting against one disease may be a 
risk factor for another disease.149 The 
danger in acting on such perceived risks 
is a higher likelihood of overtreatment or 
treatment of unclear value,150 carrying 
with it risks of its own.
Finally, would knowing genetic risks 
make a difference? In many cases, the 
answer is no.
Several studies have shown that being 
advised of an increased genetic risk does 
not result in any significant change in 
health behaviors.151,152 Nor does being 
diagnosed and treated for 
hypertension,153,154 coronary heart 
disease,155 type 2 diabetes,156-159 or 
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chronic disease generally.155 A study of 
college athletes found that being advised 
of increased genetic risk of poor 
recovery from traumatic brain injury 
would not affect their playing 
behavior.160
Even surviving cancer makes little 
difference to adopting a healthy 
lifestyle.161-165 This is of particular 
concern given that cancer survivors are 
much more likely to suffer from 
comorbid chronic disease than the 
general population even where their 
lifestyle behaviors are the same.166,167 
There is growing evidence that cancer 
treatments themselves significantly 
increase the risk of subsequent 
CVD.168,169 Adopting a healthy lifestyle 
may increase the likelihood of disease-
free survival170,171 with higher levels of 
physical activity reducing the specific 
risk of CVD.172,173 The effect of chemo- 
and radiotherapy as cancer treatments on 
risk of CVD is itself a warning that 
technological approaches to health care 
(such as gene therapy) may have 
unforeseen adverse health consequences 
downstream.
With substantial evidence that knowing 
the risk of one disease does not motivate 
many people to change their behavior, 
what could we then expect of being 
advised of genetic risk of a hundred or 
more diseases? Would this be motivating, 
overwhelming, or simply unbelievable? 
Responses are likely to range from 
fatalism, panic, and tunnel vision to 
incredulity, leading to either inaction or 
to overreaction and unnecessary 
preemptive treatment. All of these 
responses could be dysfunctional, 
especially when making healthy lifestyle 
changes could provide broad-spectrum 
protection against almost all of these 
risks.
Carrying a gene that increases risk of 
one disease does not reduce risks of 
other diseases. A narrow focus on the 
one genetic risk may simply shift the risk 
to such other diseases instead. A 
meta-analysis by the Cochrane 
Collaboration on cancer screening found 
that “the trials with adequate 
randomization did not find an effect of 
screening on total cancer mortality, 
including breast cancer, after 10 years . . . 
or on all-cause mortality after 13 years.”174
Why Do Not People 
Adopt Healthy 
Lifestyle Behaviors?
We tend to make unjustified 
assumptions about human behavior 
including the assumptions that people 
are rational/irrational or that all people 
need is more information to motivate 
change.175 However, we sometimes 
overlook the fact that, for many people, 
chronic disease has low saliency and low 
perceived risk,176,177 both of which may 
need to be addressed if healthy lifestyle 
is to be promoted. There are at least 4 
barriers to healthy people adopting a 
healthier lifestyle.
First, for much of its course, chronic 
disease is essentially invisible to other 
people. We do not know what 
medications the people around us may 
be taking for a chronic disease, and it is 
only when such a disease reaches a 
critical point such as requiring dialysis, 
or amputation or other surgery, or where 
a person visibly deteriorates or needs 
mobility or other functional aids that we 
actually see evidence of chronic disease. 
This may lead many people to 
underestimate the risk. In 2014-2015, a 
massive 50% of Australians reported 
having at least 1 of 8 chronic diseases.178 
Yet in the mass media, there is virtual 
silence regarding the prevalence such 
diseases. Paradoxically, those at highest 
risk of chronic disease may perceive 
their risk to be low.179
Second, the normalization of obesity 
may reduce motivation to do anything 
about weight gain.180,181 While 
stigmatization of obesity is 
counterproductive182 and obese people 
may need additional emotional support 
for health behavior change,183 the 
validation of obesity by movements such 
as the “fat acceptance movement” 
potentially undermines public health 
efforts to combat obesity and its health 
consequences, by encouraging 
complacency and inaction.
Third, based on age-specific mortality 
rates for Australia, 90% of people in 
Western countries now live to at least 
the age of 65,184 85% to the age of 70, 
and 80% to the age of 75. So, while 
people are working, they are unlikely to 
see significant levels of mortality in 
coworkers or their age-cohort and 
would tend to associate chronic disease 
with aging, without drawing the 
connection between morbidity/mortality 
and the cumulative effect of lifestyle 
behaviors. When age-specific causes of 
death are considered for people under 
45, the main causes are suicide and 
accidents, which in themselves do not 
directly relate to factors such as diet or 
activity levels.
Finally, the very success of modern 
medicine in stabilizing chronic diseases 
(without actually curing them) may 
reduce the perceived threat. Coupled 
with social safety nets for subsidized 
health care and disability payments in 
many Western countries, reduction in the 
perceived risk of unhealthy behaviors 
may lead to more rather than less 
unhealthy behavior, the so-called “Fence 
Paradox,”185 due to the reduced costs 
involved to the individual.186 One such 
example is HIV prophylaxis and 
treatment.187-189
Can Genetic Risk 
Actually Be Predicted 
With Precision?
A number of recent studies claim to be 
able to predict risk of CVD with accuracy 
as great as or better than conventional 
clinical measures. One study190 generated 
a genetic risk score (GRS) based on 
49310 SNPs (single nucleotide 
polymorphisms); however, when applied 
to new data gave inconsistent results for 
different populations (Finnish vs British), 
with no overlap in 95% confidence 
intervals for odds ratios for the 2 
populations. A second study191 used 1.7 
million genetic variants to generate a 
genetic risk score, but only gave a 
marginal improvement over clinical 
measures. (Interestingly another study 
using only 31 variants yielded 
comparable accuracy,192 suggesting that 
almost all of the 1.7 million variants were 
redundant.) Both of the studies using 
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large numbers of variants appear to have 
a number of methodological issues, 
including the assumption that including 
more variants of lower demonstrated 
association with CVD risk will somehow 
improve accuracy rather than simply 
adding noise.
But the greatest deficit in such studies 
is the lack of consideration of the false 
negative rate, the false positive rate, or 
specificity,193-195 any of which could have 
serious consequences196 for those whom 
a model predicts of being at high risk. 
Such models may result in overtesting, 
overdiagnosis, and overtreatment. In the 
process, more people will join the ranks 
of the “worried well,” anxious about a 
disease they will never get, hypervigilant 
for any associated symptoms, and 
perhaps less alert to symptoms of the 
genesis of an actual unrelated disease. 
There are already indications that some 
genetic associations may be spurious 
with the same SNP showing increased 
risk in some populations but not 
others.197-199 Some researchers argue for a 
more rigorous approach to determining 
causality200 and a greater focus on 
biological mechanisms,201 with one 
recent survey even casting doubt on 
whether extensive genetic data will ever 
be useful for making reliable causal 
inferences.202 In many studies, rather 
than all of the SNPs being verified as 
present, they are imputed algorithmically. 
In the UK Biobank of around 500 000 
people, used in many studies, around 
805 000 genetic markers have been 
collected that by imputation are 
increased to 95 million variants.203 Such 
high levels of imputation raise 
reasonable concerns about the results of 
such research.
The human genome is incredibly 
variable with the 1000 Genomes Project 
finding more than 88 million variants in 
just 2504 individuals.204 Such vast 
numbers of genetic variants or SNPs can 
only be accommodated into existing 
statistical methods by aggregating them 
and then stratifying the aggregated 
values, automatically resulting in loss of 
information.205 Different genes may 
promote heart disease via different 
pathways, for example, by increasing 
endogenous cholesterol or by 
moderating lipid metabolism, anti-
inflammatory processes, or antioxidant 
defenses. But the grab-bag approach of 
throwing them all into a homogeneous 
category means that even if risk is 
established from the GRS it provides no 
guidance as to how it should be 
mitigated and thus has to fall back on 
blanket treatments, which could be 
ineffective for the gene variant the 
individual actually has. Unless the 
functional role of a SNP is established 
and how that function relates to 
increased risk of CVD, it may simply be 
a chance artefact of testing thousands or 
millions of variants. Extending a 
predictive model beyond a few dozen 
variants may not result in increased 
predictive power.206,207 One study that 
looked at the clinically confirmed 
severity of coronary artery disease and 
genotype data imputed to 2.5 million 
SNPs was only able to confirm a single, 
already known, locus as a risk for 
severity of coronary artery disease.208
Genomic prediction probably will not 
markedly improve in the future simply 
because the most common variants with 
moderate to high association with 
chronic disease have already been 
identified,209 that is, the low-hanging fruit 
have already been picked.210 As Fröhlich 
and coauthors state,
The lack of impact on clinical practice 
can largely be attributed to insufficient 
performance of predictive models, 
difficulties to interpret complex model 
predictions, and lack of validation via 
prospective clinical trials that 
demonstrate a clear benefit compared 
to the standard of care.211
A recent study, using only 48 SNPs, 
identified from genome-wide association 
studies, found that GRS and diet were 
independently associated with risk of 
T2D and concluded that everyone 
regardless of genetic risk would benefit 
from favorable food choices.212 
Identifying increased genetic risk of 
CVD, T2D, or cancer would not 
significantly change recommendations 
for a healthy lifestyle. The massive 
increase in chronic disease since the 
mid-20th century has been driven, not by 
a massive change in the genetic make-up 
of the population but by changes in 
lifestyle and environmental exposures.
What Is the Future of 
Lifestyle Medicine?
Lifestyle medicine ultimately aims to 
make a healthy lifestyle the norm rather 
than the exception. This means finding 
better strategies to promote a healthy 
lifestyle, helping individuals adopt and 
sustain such a lifestyle, and combatting 
the detrimental effects of an obesogenic 
environment. The maximum gains to be 
made in reducing chronic disease still lie 
in a focus on improving health behaviors 
for people generally rather than a focus 
on outliers, simply because of the high 
prevalence of unhealthy lifestyles.
At the risk of seeming Luddite, the 
future of lifestyle medicine is humanistic 
rather than technological. It needs to 
focus on how more people can be 
induced to adopt a healthy lifestyle and 
how such a lifestyle can be sustained 
and become habitual.213 Whereas limited 
frequency health behaviors such as 
vaccinations and screening are relatively 
easy to promote, a healthy lifestyle 
requires repeated-occurrence health 
behaviors and continued abstention from 
unhealthy behaviors across the entire 
lifespan,214 a much tougher proposition.
The obesogenic environment is a 
continuing, if not rising, problem (with 
digital technology a contributor toward 
increased obesity).215 An analogous 
approach may need to be taken to 
unhealthy foods as has been successfully 
taken with smoking, including things 
such as banning advertising and 
promotion of unhealthy foods aimed at 
children, increasing sales taxes on 
unhealthy food items, or subsidies on 
fruit and vegetables to increase their 
affordability.216 However, we still need to 
make a distinction between the 
environment as a stimulus and individual 
responsibility for what people do in 
response to that stimulus. If individuals 
are not ultimately responsible for their 
own health behaviors, health promotion 
becomes irrelevant. Environmental 
175
vol. 14 • no. 2 American Journal of Lifestyle Medicine
triggers alone do not cause unhealthy 
lifestyles. On a more positive note, there 
is some evidence that healthy behaviors 
may be becoming more prevalent at least 
in the Asia-Pacific region (including 
Australia and New Zealand).217
Another area on which lifestyle 
medicine needs to focus is making better 
use of “teachable moments,” particularly 
those times where a patient is advised of 
a risk or diagnosis218-220 or where they 
have been successfully treated but face 
increased risk of co-morbidity.
Increasing our effectiveness in helping 
individuals sustain healthy behaviors 
requires acknowledging the ways in 
which they differ in the kinds of 
messages that they find sufficiently 
persuasive to result in action,221,222 in the 
misinformation and misperceptions they 
may have,223 in how they differ in their 
motivations224 and in their ability to 
implement and sustain changes, and in 
how their social environment can 
support or undermine change.
Lifestyle medicine also needs to more 
deeply explore how mental health risks 
may be reduced via health behavioral 
change.225 This is of increasing concern 
given the huge increase in the rate of 
anti-depressant use in Western societies. 
Finally, we may need to embrace ideas 
that have historically been considered to 
lie within the ambit of spirituality, with 
numerous studies finding positive 
associations between religious 
participation and physical and mental 
health226-228 as well as associations with 
particular components of religious 
attitudes such as generosity.196,229
Lifestyle medicine’s future may 
ultimately lie in individualizing support 
so that adopted lifestyle behaviors 
become permanent rather than transient.
Individualizing Support
There are several excellent resources 
dealing in detail with individualizing 
exercise recommendations for chronic 
disease.230-234 In addition, Minich and 
Bland’s coverage of issues relating to 
special dietary considerations is also 
wide-ranging.235 So, the issues 
concerning physical aspects of lifestyle 
will be covered only briefly here, 
followed by further discussion about 
personalization of lifestyle medicine in 3 
areas: social connectedness, 
psychological skills and support, and 
basic practical skills.
Exercise and Activity
For physical activity, the most critical 
aspect is to start with activities that lie 
within the individual’s capabilities but 
which serve to extend those capabilities 
over time. This is particularly necessary 
where individuals suffer from chronic 
diseases, which may cause dysfunction at 
the cellular level, but which may improve 
over time with diet and activity. 
Individuals differ in response to exercise 
depending on the intensity, frequency, 
duration, and modality, as well as on the 
timing and composition of meals,236 so 
exercise needs to be tailored to the 
individual237 to elicit the best response 
for that person.238 For some people, 
exercise (not activity) may lead to 
adverse effects on blood pressure, high-
density lipoprotein cholesterol or other 
biomarkers or symptoms239 so a more 
gradual approach, with more biometric 
monitoring, could be warranted for such 
individuals.
There is some evidence of nonresponse 
to particular kinds of exercise for some 
people,240 which could mean 
experimenting to see what works best at 
a given time for a given individual at a 
particular stage of chronic disease.241-243 
Compensatory behavior, such as 
increased eating or reduced activity, may 
negate any benefits,244-246 so this may 
also need to be addressed.
While there is evidence that 
personalized exercise prescription may 
enhance response,237 at this point the 
specific use of genetic information to 
inform exercise prescription may be 
premature. A 2017 review of genetic 
testing for exercise prescription and 
injury prevention found that “the 
predictive value of such tests is too low 
to warrant clinical application.”247 A 
systematic review of VO
2
-max trainability 
found that of 97 genes identified as 
possible predictors only 13 were 
reproduced in more than 2 studies and 
that heterogeneity in the studies limited 
the conclusions that could be drawn.248 
The META-PREDICT study, which 
involved developing predictors, based 
largely on genetics, for the health 
benefits of exercise for individuals 
appears to have quietly died following its 
final report in 2016.249
Individuals vary considerably in their 
affective response to exercise intensity. 
Most people have a positive response to 
moderate-intensity exercise while having 
an aversive response to higher 
intensities.250 Additionally, people who 
have more positive feelings about 
exercise are more likely to engage in 
it.250 So for an individual to continue to 
want to exercise they need to feel good 
as a result of the exercise,251,252 and it 
needs to be set at a level that best 
balances effectiveness and affective 
response, with an initial focus on 
increasing enjoyment of physical 
activity.253 Taking individual differences 
into account is crucial for effective 
physical activity interventions.254
Nutrition
The effects of some nutrients may differ 
in people with different gene variants, 
although the evidence is often mixed. 
While increased requirements for certain 
micronutrients have been established 
beyond doubt for some people (eg, 
folate for pregnant women to prevent 
neural tube defects and anencephaly),255 
most findings that relate genetics to 
nutrient requirements find either small 
effect sizes or conflicting evidence for 
the direction of the effect. For example, 
an examination of genetic variations and 
zinc requirements256 concluded that “the 
data extracted confirmed a connection 
between genetics and zinc requirements, 
although the direction and magnitude of 
the dietary modification for carriers of 
specific genotypes could not be defined.”
In 3 studies (all by the same 
researchers) of interaction of DHA with 
the APOE4 gene (a risk factor for 
Alzheimer’s disease [AD]),257 one study 
found limited transfer of DHA to 
cerebrospinal fluid,258 another study 
using a different measurement method 
found increased brain-uptake of DHA for 
the same gene,259 while a third study 
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suggested that high-dose DHA in early 
stages of AD dementia could decrease 
prevalence in APOE4 carriers.260 Other 
studies have found improved cognitive 
function with fish oil supplementation 
only in APOE4 carriers261 or conversely 
no benefit only for APOE4 carriers.262 
The bottom line is that we simply do not 
know what the interaction is, if any.
One difficulty in linking micronutrients 
with chronic disease is that if an 
individual has a high-energy, nutrient-
poor diet, then, rather than nutritional 
deficiency being the cause of the disease 
(eg, obesity), both the disease and 
nutritional deficiency may be attributable 
to diet quality. Accurately measuring 
nutrient intake and nutritional needs for 
micronutrients for individuals is 
extremely challenging,263 so rather than 
focusing on specific nutrients, the safest 
approach is a varied diet of healthy 
foods,264 adjusting for particular food 
sensitivities. However, including 
unhealthy foods in a varied diet may 
actually increase risk of abdominal 
obesity and T2D.265
Social Connectedness
Social isolation and loneliness have 
been recognized as detrimental to 
health for more than 30 years.266 
Growing numbers of people report 
social isolation or loneliness, while 
others experience dysfunctional or 
undermining relationships that can also 
be detrimental to health or the success 
of a lifestyle medicine intervention.267 
Negative social experiences correlate 
with poorer health behaviors268 while 
loneliness tends to be associated with 
poorer social skills.269 Conversely, 
support from family, friends, or 
workmates may all contribute to a 
person making and sustaining healthy 
lifestyle changes.270 Belonging to a 
cohesive, stable, and homogeneous 
community may in itself have positive 
health benefits (the so-called Roseto 
Effect271), something that modernity 
seems to have undermined. Blue Zones 
notably involve groups who, whether 
by reason of ethnicity, isolation, or 
religious participation, constitute such 
cohesive communities.
Addressing social isolation may be a 
core factor in improving lifestyle 
behaviors, whether this involves helping 
people to improve social skills or 
facilitating participation in a stable social 
group. Face-to-face support groups272 
that persist beyond the intervention and 
peer mentoring/support (the buddy 
system)273-275 may be effective means of 
both supporting behavior change and 
reducing the negative impact of social 
isolation by providing new social ties 
and support, other than that of a paid 
health professional. They can also be 
more cost-effective,276 an important 
consideration in an era of skyrocketing 
health costs.
Social skills training and opportunities 
to practice these growing skills may help 
overcome some of the more detrimental 
emotional effects of loneliness that for 
some underpin dysfunctional health 
behaviors. Finally, the health benefits of 
volunteering277,278 may in part lie in 
increased social contact with less focus 
on self and could form part of a lifestyle 
intervention for people lacking social 
support.
Psychological Factors
Individual psychological differences 
may affect their capacity to adopt and 
sustain healthy lifestyle behaviors. How 
people deal with failure279 may influence 
abandonment of health behaviors, and it 
is possible that similar strategies for 
dealing with relapse could be utilized as 
for addiction.280 One possible future 
research direction may be how 
individuals deal with micro-temporal 
factors such as temporal and situational 
cues, as well as transient thoughts and 
feelings.214 Individuals also differ on 
multiple dimensions on how they 
approach goal setting and 
achievement,281 so finding the best 
approach for the individual may be 
essential for long-term success. One key 
strategy may be planning in advance 
how to deal with obstacles or setbacks282 
and using implementation intentions, 
which has shown promise in terms of 
reducing meat consumption283 and 
increasing physical activity.284 Individuals 
may have chronic diseases as a result of 
past self-regulatory failure and may need 
training in a range of skills such as 
planning, mental contrasting, distracting, 
and reframing.285 Motivational 
interviewing and health coaching have 
proven effective in assisting individuals 
in meeting their health goals286-288 and 
may help individuals build self-efficacy.
For individuals with multiple 
comorbidities, regimen factors,289 burden 
of treatment,290 and patient capacity291 
may all need to be considered in 
deciding what approach to take with 
promoting lifestyle changes for 
individuals who may already be 
struggling to cope. An approach known 
as “minimally disruptive medicine” may 
be needed.292 In some cases, 
implementing small changes may be the 
best approach to take293 with a focus on 
progress rather than perfection.
Skills Training
For many individuals, just knowing 
what they should be eating is not 
enough, they need to be given the skills 
to put those recommendations into 
practice. In order to be able to eat 
healthily, an individual may need to learn 
basic cooking and shopping skills and 
strategies. Teaching basic cooking skills 
has been shown to encourage healthy 
eating,294-297 with home-cooked meals 
associated with better dietary quality.298 
Community interventions to improve 
cooking skills have been shown to 
increase food literacy,299 while 
incorporating cooking demonstrations 
and opportunities to taste healthier foods 
as part of a health promotion program 
could help encourage healthier eating.300 
Using a grocery list when shopping is 
also associated with a healthier diet 
among high risk adults301 and healthy 
shopping tours are being increasingly 
offered by health organizations.
Conclusion
Precision or genomic medicine is not 
the enemy.302 There may be some scope 
for cross-fertilization between the 2 
specializations. For individuals who 
conscientiously adopt a healthy lifestyle 
but show no improvement in biomarkers, 
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genetic research could help identify 
whether there is a genetic explanation or 
whether there is some previously 
unknown lifestyle or environmental 
factor that needs to be considered. 
Conversely longitudinal research on 
populations who live a healthy lifestyle 
could help sharpen estimates of gene 
penetrance paving the way to better 
predictive models. Such research could 
possibly even help identify new lifestyle 
factors by looking at differences in 
outcome between genetically similar 
people following the same healthy 
lifestyle.
However, chronic disease is simply not 
the primary target for a genetic 
approach and extending it to the broad 
mass of people at low genetic risk is 
overkill. Precision medicine is best 
targeted at gene therapy for gene 
variants with proven etiology, identifying 
genetic factors in variations in drug 
effectiveness and identifying high 
penetrance genes for disease 
screening.209 Primary genetic research 
may also identify links between diseases 
and the functions of genes and gene 
networks that may lead to novel insights 
into the genesis of disease.303,304
While this article has identified 
technical barriers to a genuinely 
“precision” medicine, there are also 
numerous ethical issues305-307 and 
regulatory protections that would need 
to be ironed out should such an 
approach become the dominant 
paradigm.308 These include things such 
as informed consent, continued 
ownership of one’s own genetic 
information309 and the right to have it 
destroyed, privacy (especially in an era 
where data leaks are so common and 
where depersonalized data can be 
re-personalized310), genetic 
discrimination, the right to refuse genetic 
testing, and the potential for future abuse 
by governments.311 Precision medicine 
has been described as “drowning in a 
regulatory soup.”312 The demand for ever 
bigger genomic data sets and ever more 
personal medical information with which 
to match it, combined with the rush by 
governments to accommodate these 
demands, is likely to lead to fundamental 
human rights and freedoms being 
overridden. There are already calls for 
every newborn to be genetically 
sequenced313 with the consequent 
medicalization of life.
None of these concerns apply to 
lifestyle medicine.
We currently seem to be at the “Peak of 
Inflated Expectations,”314 and it may be 
some years before the limited utility of 
precision medicine is recognized and 
that projected cost savings are illusory.315 
The financial resources being allocated, 
for what is effectively a promissory note, 
may ultimately divert resources from the 
more acute problem: How can we 
persuade most people to adopt a healthy 
lifestyle?316
Lifestyle medicine now possesses a 
much deeper scientific foundation but 
the actual recommendations have not 
markedly changed as a result. The 
fundamental problem for lifestyle 
medicine remains: How people can be 
motivated to adopt, sustain, and 
ultimately naturalize a healthy lifestyle. 
Rather than delving ever more deeply 
into physical mechanisms, instead we 
need to look at the psychological and 
social factors that either encourage or 
obstruct healthy lifestyle behaviors. 
Interventions need to be personalized 
to the individual and their embodied 
experience of the world. This does not 
necessarily mean changing what we 
recommend, but it does mean 
changing how we support the 
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